These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27048405)

  • 1. Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study.
    van der Does Y; Limper M; Schuit SC; Poley MJ; van Rosmalen J; Ramakers C; Patka P; van Gorp EC; Rood PP
    BMC Emerg Med; 2016 Apr; 16():17. PubMed ID: 27048405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
    Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
    Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.
    Nijman RG; Moll HA; Smit FJ; Gervaix A; Weerkamp F; Vergouwe Y; de Rijke YB; Oostenbrink R
    Pediatr Infect Dis J; 2014 Nov; 33(11):e273-9. PubMed ID: 25093971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.
    Andreola B; Bressan S; Callegaro S; Liverani A; Plebani M; Da Dalt L
    Pediatr Infect Dis J; 2007 Aug; 26(8):672-7. PubMed ID: 17848876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
    de Kruif MD; Limper M; Gerritsen H; Spek CA; Brandjes DP; ten Cate H; Bossuyt PM; Reitsma PH; van Gorp EC
    Crit Care Med; 2010 Feb; 38(2):457-63. PubMed ID: 20083920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.
    van der Does Y; Rood PPM; Ramakers C; Schuit SCE; Patka P; van Gorp ECM; Limper M
    Clin Microbiol Infect; 2018 Dec; 24(12):1297-1304. PubMed ID: 30268671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of procalcitonin for hospitalised children with acute pyelonephritis presenting to the paediatric emergency department.
    Chen SM; Chang HM; Hung TW; Chao YH; Tsai JD; Lue KH; Sheu JN
    Emerg Med J; 2013 May; 30(5):406-10. PubMed ID: 22645218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin.
    Olaciregui I; Hernández U; Muñoz JA; Emparanza JI; Landa JJ
    Arch Dis Child; 2009 Jul; 94(7):501-5. PubMed ID: 19158133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department.
    Kasem AJ; Bulloch B; Henry M; Shah K; Dalton H
    Pediatr Emerg Care; 2012 Oct; 28(10):1017-21. PubMed ID: 23023470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.
    Hausfater P; Juillien G; Madonna-Py B; Haroche J; Bernard M; Riou B
    Crit Care; 2007; 11(3):R60. PubMed ID: 17521430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
    Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
    Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.
    Magrini L; Gagliano G; Travaglino F; Vetrone F; Marino R; Cardelli P; Salerno G; Di Somma S
    Clin Chem Lab Med; 2014 Oct; 52(10):1465-72. PubMed ID: 24803611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
    Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
    Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.